跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Buscopan Plus - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Buscopan Plus
Approved
STANDARD
Buscopan Plus
Sanofi Vietnam Shareholding Company
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
ca4207e09905c2e5
Company
Sanofi Vietnam Shareholding Company
Type
Standard
Approval Details
Approval Id
ca4207e09905c2e5
Drug Approval Philippines Name
Buscopan Plus
Product Name
Buscopan Plus
Registration Number
DRP-3039
Brand Name
Buscopan Plus
Generic Name
Hyoscine-N-Butylbromide + Paracetamol
Dosage Form
Film Coated Tablet
Dosage Strength
10 mg /500 mg
Manufacturer
Sanofi Vietnam Shareholding Company
Importer
Opella Healthcare Philippines, Inc.
Issuance Date
24 November 2022
Expiry Date
31 May 2027
Classification
Over-the-Counter (OTC)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
ca4207e09905c2e5
Type
Standard
Back to Philippines FDA Approvals